EPHA2 and neoplasm: The EPHA2/ephrinA3axis acts as a responder to low oxygen levels, utilizes SREBP1-mediated ACLY transcription to promote metabolic reprogramming, and induces higher self-renewal and tumor-initiating capacity in HCC cells (EpCam, CD13, and CD24) [83].